Table 1.
papers | country | no. of included (excluded) cases | site of viral load data used | reporting value | detection limit (copies ml–1) | range of symptom onset | agec | sex (M : F) |
---|---|---|---|---|---|---|---|---|
Young et al. [40] | Singapore | 12 (6) | nasopharyngeal swab | cycle thresholda | 68.0 | 1/21–1/30 | 37.5 (31–56) | 6 : 6 |
Zou et al. [39] | China | 8 (8) | nasal swab | cycle thresholda | 15.3 | 1/11–1/26 | 52.5 (28–78) | 3 : 5 |
Kim et al. [41] | Korea | 2 (7) | nasopharyngeal and oropharyngeal swab | cycle thresholda | 68.0 | NA | NA | NA |
Wölfel et al. [21] | Germany | 8 (1) | pharyngeal swab | viral load (copies/swab)b | 33.3 | 1/23–2/4 | NA | NA |
acycle threshold values were converted by using the formula: log10(viral load [copies ml−1]) = −0.32 × Ct values [cycles] + 14.11 [39].
b1 swab was assumed to be 3 ml in Wölfel et al. according to the original paper.
cmedian (range).